19.07.2021 • NewsSolvay

Verdant Strengthens Surfactants with First Acquisition

Verdant Specialty Solutions, Solvay’s former amphoteric surfactants business, has acquired DeForest Enterprises and ParaFlow Energy Solutions from Chemical Services Group for an undisclosed sum.

The acquisition, said Verdant, marks an important first step in its strategy to accelerate growth through accretive acquisitions in existing and adjacent technologies and markets. Verdant CEO John Foley commented: “These two acquisitions expand our portfolio of surfactants so that we can help customers across a broader range of markets find creative solutions and capitalize on new opportunities.”

DeForest Enterprises is a specialty surfactants company while ParaFlow Energy Solutions provides products for paraffin mitigation in upstream crude oil production and technologies for use in demulsifier applications.

Both companies are based in Boca Raton, Florida, USA, and together supply more than 100 customers in markets including industrial and institutional cleaning, metalworking and metal finishing, oilfield, pigments and inks, construction and automotive care.

Verdant is a portfolio company of global private equity group OpenGate Capital, which bought Solvay’s secondary surfactants business on Apr. 30 and renamed it. Verdant employs approximately 175 staff and operates three main production sites in University Park, Illinois, USA; Halifax, UK, and Genthin, Germany, as well as a tolling business in Turkey. It is headquartered in Houston, Texas, USA.

Author: Elaine Burridge, Freelance Journalist

Verdant Specialty Solutions, Solvay’s former amphoterics surfactants...
Verdant Specialty Solutions, Solvay’s former amphoterics surfactants business, has bought DeForest Enterprises and ParaFlow Energy Solutions, making a first step in its strategy to accelerate growth through accretive acquisitions in existing and adjacent technologies and markets. (c) Verdant Specialty Solutions

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.